See also this year's filing and all EDGAR filings for this company.
PDF Report 0001267813_2023_Marinus_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 2.673828406633021, 'aggregate_val': 25478000, 'exp_sum': 6935000, 'exp_to_value': {'remainder_Revenues': 6935000}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 1.7245472129417971, 'aggregate_val': 30989000, 'exp_sum': 11374000, 'exp_to_value': {'remainder_Revenues': 11374000}} |
Graph
Absolute values for 0001267813, Marinus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 252,378,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,236,000 |
| 3 | remainder_Assets | 2,904,000 |
| 4 | LiabilitiesCurrent | 25,017,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 118,501,000 |
| 7 | CostOfGoodsAndServicesSold | 1,450,540 |
| 8 | SellingGeneralAndAdministrativeExpense | 77,601,178 |
| 9 | ResearchAndDevelopmentExpense | 80,520,650 |
| 10 | remainder_Expenses | 80,489,617 |
| 11 | remainder_Revenues | 42,704,658 |
| 12 | remainder_NetIncome | 637,720,984 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 259,518,000 |
| 1 | Liabilities | 143,518,000 |
| 2 | Expenses | 240,061,985 |
| 3 | Revenues | 42,704,658 |
| 4 | StockholdersEquity | 116,000,000 |
| 5 | NetIncome | 440,363,657 |
| 6 | ComprehensiveNetIncome | 440,363,657 |
| 7 | BaseVar | 661,761,814 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.44 |
| 9 | EconomicCapitalRatio | 3.99 |
Edgar->Model Mapping
Feature Distribution
Change over Time
